---
base_model: BAAI/bge-base-en-v1.5
datasets: []
language: []
library_name: sentence-transformers
metrics:
- cosine_accuracy@1
- cosine_accuracy@3
- cosine_accuracy@5
- cosine_accuracy@10
- cosine_precision@1
- cosine_precision@3
- cosine_precision@5
- cosine_precision@10
- cosine_recall@1
- cosine_recall@3
- cosine_recall@5
- cosine_recall@10
- cosine_ndcg@10
- cosine_mrr@10
- cosine_map@100
pipeline_tag: sentence-similarity
tags:
- sentence-transformers
- sentence-similarity
- feature-extraction
- generated_from_trainer
- dataset_size:76
- loss:MatryoshkaLoss
- loss:MultipleNegativesRankingLoss
widget:
- source_sentence: ply C Tris pH8.0 Dextran Trehalose dNTPS Na2 SO4 Triton X-100
sentences:
- NE
- Assignee
- ID NO
- source_sentence: Certain isothermal amplification methods are able to amplify
a target nucleic acid from trace levels to very high 25 and detectable levels within a matter of minutes. Such
isothermal methods, e.g., Nicking and Extension Amplifi cation Reaction (NEAR), allow
users to detect a particular nucleotide sequence in trace amounts, facilitating
point-of care testing and increasing the accessibility and speed of diagnostics.
Streptococcus pyogenes is the causative agent of group A streptococcal (GAS) infections such as pharyngitis, impe
tigo, and life-threatening necrotizing fasciitis and sepsis. The most common GAS infection, pharyngitis, can be
diagnosed by collecting a throat swab sample from a patient and culturing the
sample under conditions that would enable bacterial, specifically S. pyogenes, growth,
which takes 2-3 days. Culturing S. pyogenes is an accurate and reliable
method of diagnosing GAS, but it is slow. A 2-3 day delay in prescribing appropriate antibiotic
treatment can result in unnecessary patient suffering and potentially the onset
oflife threatening conditions such as rheumatic fever. In the recent past, biochemical
methods have been developed to detect S. pyogenes, but these methods do not provide the necessary
characteristics to be deployed in the point-of-care setting, either due to a lack
of sensitivity or time to result (speed). Accordingly, a highly sensitive and
rapid qualitative assay for the detection and diagnosis of a S. pyogenes infection
is desired.
sentences:
- ABSTRACT
- TACTGTTCCTGTTTGA
- BACKGROUND
- source_sentence: W02010/141940 12/2010 CA (US)
sentences:
- WO
- DESCRIPTION OF DRAWINGS
- SUMMARY
- source_sentence: 9 6 nucleotide sequence at least 80, 85 or 95% identity to SEQ
sentences:
- '2'
- NEAR
- Ph. Dissertation published Jan. 1, 2008. (Year
- source_sentence: One potential inhibitor of the NEAR technology is human gDNA. When a throat swab sample is collected from a
patient symptomatic for GAS infection, it is possible that human gDNA
is also collected on the swab (from immune cells such as white blood cells
or from local epithelial cells). In order to assess the impact that human gDNA
has on the GAS assay, a study was performed using three different levels of
GAS gDNA (25, 250 and 1000 copies) in the presence of 0, 10, 50, 100, 250, 500 or 1000
ng of human gDNA. As shown in FIG. 6, the presence of human gDNA does have an impact on
GAS assay performance, and the impact is GAS target concentration dependent. When
there is a low copy number of target GAS present in the reaction, 10 ng of
human gDNA or more significantly inhibits the assay. At 250 copies of GAS
target, the impact of 10 ng of 60 human gDNA is less, and at 1,000 copies of
GAS target, the effect of 10 ng of human gDNA on the assay is significantly less. In
fact, when 1,000 copies of target is present in the assay, up to 100 ng
of human gDNA can be tolerated, albeit with a slower amplification speed and reduced
fluorescence signal. Testing of the 501 (IC only) mix showed a more robust response to human gDNA. When the 501 mix was
tested in the presence of O copies of target GAS and up to US 10,329,601 B2
23 1,000 ng of human gDNA, the assay still produced a clearly positive signal
at 500 ng of human gDNA (even at 1,000 ng of human gDNA the fluorescence signal was still above
background). Other Embodiments It is to be understood that while the invention
has been described in conjunction with the detailed description 24 thereof, the foregoing description is intended to illustrate
and not limit the scope of the invention, which is defined by the scope of the
appended claims. Other aspects, advantages, and modifications are within the scope of
the following claims.
sentences:
- '75'
- TGTAGCTGACACCACCAAGCTACA
- Impact of Human Genomic DNA (gDNA) on GAS Assay
model-index:
- name: SentenceTransformer based on BAAI/bge-base-en-v1.5
results:
- task:
type: information-retrieval
name: Information Retrieval
dataset:
name: dim 768
type: dim_768
metrics:
- type: cosine_accuracy@1
value: 0.625
name: Cosine Accuracy@1
- type: cosine_accuracy@3
value: 0.875
name: Cosine Accuracy@3
- type: cosine_accuracy@5
value: 1.0
name: Cosine Accuracy@5
- type: cosine_accuracy@10
value: 1.0
name: Cosine Accuracy@10
- type: cosine_precision@1
value: 0.625
name: Cosine Precision@1
- type: cosine_precision@3
value: 0.29166666666666663
name: Cosine Precision@3
- type: cosine_precision@5
value: 0.2
name: Cosine Precision@5
- type: cosine_precision@10
value: 0.1
name: Cosine Precision@10
- type: cosine_recall@1
value: 0.625
name: Cosine Recall@1
- type: cosine_recall@3
value: 0.875
name: Cosine Recall@3
- type: cosine_recall@5
value: 1.0
name: Cosine Recall@5
- type: cosine_recall@10
value: 1.0
name: Cosine Recall@10
- type: cosine_ndcg@10
value: 0.8202007889556063
name: Cosine Ndcg@10
- type: cosine_mrr@10
value: 0.7604166666666666
name: Cosine Mrr@10
- type: cosine_map@100
value: 0.7604166666666666
name: Cosine Map@100
- task:
type: information-retrieval
name: Information Retrieval
dataset:
name: dim 512
type: dim_512
metrics:
- type: cosine_accuracy@1
value: 0.625
name: Cosine Accuracy@1
- type: cosine_accuracy@3
value: 0.875
name: Cosine Accuracy@3
- type: cosine_accuracy@5
value: 0.875
name: Cosine Accuracy@5
- type: cosine_accuracy@10
value: 1.0
name: Cosine Accuracy@10
- type: cosine_precision@1
value: 0.625
name: Cosine Precision@1
- type: cosine_precision@3
value: 0.29166666666666663
name: Cosine Precision@3
- type: cosine_precision@5
value: 0.17500000000000002
name: Cosine Precision@5
- type: cosine_precision@10
value: 0.1
name: Cosine Precision@10
- type: cosine_recall@1
value: 0.625
name: Cosine Recall@1
- type: cosine_recall@3
value: 0.875
name: Cosine Recall@3
- type: cosine_recall@5
value: 0.875
name: Cosine Recall@5
- type: cosine_recall@10
value: 1.0
name: Cosine Recall@10
- type: cosine_ndcg@10
value: 0.810892117584935
name: Cosine Ndcg@10
- type: cosine_mrr@10
value: 0.75
name: Cosine Mrr@10
- type: cosine_map@100
value: 0.75
name: Cosine Map@100
- task:
type: information-retrieval
name: Information Retrieval
dataset:
name: dim 256
type: dim_256
metrics:
- type: cosine_accuracy@1
value: 0.625
name: Cosine Accuracy@1
- type: cosine_accuracy@3
value: 0.875
name: Cosine Accuracy@3
- type: cosine_accuracy@5
value: 0.875
name: Cosine Accuracy@5
- type: cosine_accuracy@10
value: 1.0
name: Cosine Accuracy@10
- type: cosine_precision@1
value: 0.625
name: Cosine Precision@1
- type: cosine_precision@3
value: 0.29166666666666663
name: Cosine Precision@3
- type: cosine_precision@5
value: 0.17500000000000002
name: Cosine Precision@5
- type: cosine_precision@10
value: 0.1
name: Cosine Precision@10
- type: cosine_recall@1
value: 0.625
name: Cosine Recall@1
- type: cosine_recall@3
value: 0.875
name: Cosine Recall@3
- type: cosine_recall@5
value: 0.875
name: Cosine Recall@5
- type: cosine_recall@10
value: 1.0
name: Cosine Recall@10
- type: cosine_ndcg@10
value: 0.8057993287946483
name: Cosine Ndcg@10
- type: cosine_mrr@10
value: 0.7447916666666666
name: Cosine Mrr@10
- type: cosine_map@100
value: 0.7447916666666666
name: Cosine Map@100
- task:
type: information-retrieval
name: Information Retrieval
dataset:
name: dim 128
type: dim_128
metrics:
- type: cosine_accuracy@1
value: 0.75
name: Cosine Accuracy@1
- type: cosine_accuracy@3
value: 0.875
name: Cosine Accuracy@3
- type: cosine_accuracy@5
value: 1.0
name: Cosine Accuracy@5
- type: cosine_accuracy@10
value: 1.0
name: Cosine Accuracy@10
- type: cosine_precision@1
value: 0.75
name: Cosine Precision@1
- type: cosine_precision@3
value: 0.29166666666666663
name: Cosine Precision@3
- type: cosine_precision@5
value: 0.2
name: Cosine Precision@5
- type: cosine_precision@10
value: 0.1
name: Cosine Precision@10
- type: cosine_recall@1
value: 0.75
name: Cosine Recall@1
- type: cosine_recall@3
value: 0.875
name: Cosine Recall@3
- type: cosine_recall@5
value: 1.0
name: Cosine Recall@5
- type: cosine_recall@10
value: 1.0
name: Cosine Recall@10
- type: cosine_ndcg@10
value: 0.8608566009043177
name: Cosine Ndcg@10
- type: cosine_mrr@10
value: 0.8166666666666667
name: Cosine Mrr@10
- type: cosine_map@100
value: 0.8166666666666667
name: Cosine Map@100
- task:
type: information-retrieval
name: Information Retrieval
dataset:
name: dim 64
type: dim_64
metrics:
- type: cosine_accuracy@1
value: 0.75
name: Cosine Accuracy@1
- type: cosine_accuracy@3
value: 0.875
name: Cosine Accuracy@3
- type: cosine_accuracy@5
value: 1.0
name: Cosine Accuracy@5
- type: cosine_accuracy@10
value: 1.0
name: Cosine Accuracy@10
- type: cosine_precision@1
value: 0.75
name: Cosine Precision@1
- type: cosine_precision@3
value: 0.29166666666666663
name: Cosine Precision@3
- type: cosine_precision@5
value: 0.2
name: Cosine Precision@5
- type: cosine_precision@10
value: 0.1
name: Cosine Precision@10
- type: cosine_recall@1
value: 0.75
name: Cosine Recall@1
- type: cosine_recall@3
value: 0.875
name: Cosine Recall@3
- type: cosine_recall@5
value: 1.0
name: Cosine Recall@5
- type: cosine_recall@10
value: 1.0
name: Cosine Recall@10
- type: cosine_ndcg@10
value: 0.8608566009043177
name: Cosine Ndcg@10
- type: cosine_mrr@10
value: 0.8166666666666667
name: Cosine Mrr@10
- type: cosine_map@100
value: 0.8166666666666667
name: Cosine Map@100
---
# SentenceTransformer based on BAAI/bge-base-en-v1.5
This is a [sentence-transformers](https://www.SBERT.net) model finetuned from [BAAI/bge-base-en-v1.5](https://huggingface.co/BAAI/bge-base-en-v1.5). It maps sentences & paragraphs to a 768-dimensional dense vector space and can be used for semantic textual similarity, semantic search, paraphrase mining, text classification, clustering, and more.
## Model Details
### Model Description
- **Model Type:** Sentence Transformer
- **Base model:** [BAAI/bge-base-en-v1.5](https://huggingface.co/BAAI/bge-base-en-v1.5)
- **Maximum Sequence Length:** 512 tokens
- **Output Dimensionality:** 768 tokens
- **Similarity Function:** Cosine Similarity
### Model Sources
- **Documentation:** [Sentence Transformers Documentation](https://sbert.net)
- **Repository:** [Sentence Transformers on GitHub](https://github.com/UKPLab/sentence-transformers)
- **Hugging Face:** [Sentence Transformers on Hugging Face](https://huggingface.co/models?library=sentence-transformers)
### Full Model Architecture
```
SentenceTransformer(
(0): Transformer({'max_seq_length': 512, 'do_lower_case': True}) with Transformer model: BertModel
(1): Pooling({'word_embedding_dimension': 768, 'pooling_mode_cls_token': True, 'pooling_mode_mean_tokens': False, 'pooling_mode_max_tokens': False, 'pooling_mode_mean_sqrt_len_tokens': False, 'pooling_mode_weightedmean_tokens': False, 'pooling_mode_lasttoken': False, 'include_prompt': True})
(2): Normalize()
)
```
## Usage
### Direct Usage (Sentence Transformers)
First install the Sentence Transformers library:
```bash
pip install -U sentence-transformers
```
Then you can load this model and run inference.
```python
from sentence_transformers import SentenceTransformer
# Download from the 🤗 Hub
model = SentenceTransformer("kr-manish/fine-tuned-bge-base-raw_pdf-v1")
# Run inference
sentences = [
'One potential inhibitor of the NEAR technology is human gDNA. When a throat swab sample is collected from a patient symptomatic for GAS infection, it is possible that human gDNA is also collected on the swab (from immune cells such as white blood cells or from local epithelial cells). In order to assess the impact that human gDNA has on the GAS assay, a study was performed using three different levels of GAS gDNA (25, 250 and 1000 copies) in the presence of 0, 10, 50, 100, 250, 500 or 1000 ng of human gDNA. As shown in FIG. 6, the presence of human gDNA does have an impact on GAS assay performance, and the impact is GAS target concentration dependent. When there is a low copy number of target GAS present in the reaction, 10 ng of human gDNA or more significantly inhibits the assay. At 250 copies of GAS target, the impact of 10 ng of 60 human gDNA is less, and at 1,000 copies of GAS target, the effect of 10 ng of human gDNA on the assay is significantly less. In fact, when 1,000 copies of target is present in the assay, up to 100 ng of human gDNA can be tolerated, albeit with a slower amplification speed and reduced fluorescence signal. Testing of the 501 (IC only) mix showed a more robust response to human gDNA. When the 501 mix was tested in the presence of O copies of target GAS and up to US 10,329,601 B2 23 1,000 ng of human gDNA, the assay still produced a clearly positive signal at 500 ng of human gDNA (even at 1,000 ng of human gDNA the fluorescence signal was still above background). Other Embodiments It is to be understood that while the invention has been described in conjunction with the detailed description 24 thereof, the foregoing description is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims. Other aspects, advantages, and modifications are within the scope of the following claims.',
'Impact of Human Genomic DNA (gDNA) on GAS Assay',
'TGTAGCTGACACCACCAAGCTACA',
]
embeddings = model.encode(sentences)
print(embeddings.shape)
# [3, 768]
# Get the similarity scores for the embeddings
similarities = model.similarity(embeddings, embeddings)
print(similarities.shape)
# [3, 3]
```
## Evaluation
### Metrics
#### Information Retrieval
* Dataset: `dim_768`
* Evaluated with [InformationRetrievalEvaluator
](https://sbert.net/docs/package_reference/sentence_transformer/evaluation.html#sentence_transformers.evaluation.InformationRetrievalEvaluator)
| Metric | Value |
|:--------------------|:-----------|
| cosine_accuracy@1 | 0.625 |
| cosine_accuracy@3 | 0.875 |
| cosine_accuracy@5 | 1.0 |
| cosine_accuracy@10 | 1.0 |
| cosine_precision@1 | 0.625 |
| cosine_precision@3 | 0.2917 |
| cosine_precision@5 | 0.2 |
| cosine_precision@10 | 0.1 |
| cosine_recall@1 | 0.625 |
| cosine_recall@3 | 0.875 |
| cosine_recall@5 | 1.0 |
| cosine_recall@10 | 1.0 |
| cosine_ndcg@10 | 0.8202 |
| cosine_mrr@10 | 0.7604 |
| **cosine_map@100** | **0.7604** |
#### Information Retrieval
* Dataset: `dim_512`
* Evaluated with [InformationRetrievalEvaluator
](https://sbert.net/docs/package_reference/sentence_transformer/evaluation.html#sentence_transformers.evaluation.InformationRetrievalEvaluator)
| Metric | Value |
|:--------------------|:---------|
| cosine_accuracy@1 | 0.625 |
| cosine_accuracy@3 | 0.875 |
| cosine_accuracy@5 | 0.875 |
| cosine_accuracy@10 | 1.0 |
| cosine_precision@1 | 0.625 |
| cosine_precision@3 | 0.2917 |
| cosine_precision@5 | 0.175 |
| cosine_precision@10 | 0.1 |
| cosine_recall@1 | 0.625 |
| cosine_recall@3 | 0.875 |
| cosine_recall@5 | 0.875 |
| cosine_recall@10 | 1.0 |
| cosine_ndcg@10 | 0.8109 |
| cosine_mrr@10 | 0.75 |
| **cosine_map@100** | **0.75** |
#### Information Retrieval
* Dataset: `dim_256`
* Evaluated with [InformationRetrievalEvaluator
](https://sbert.net/docs/package_reference/sentence_transformer/evaluation.html#sentence_transformers.evaluation.InformationRetrievalEvaluator)
| Metric | Value |
|:--------------------|:-----------|
| cosine_accuracy@1 | 0.625 |
| cosine_accuracy@3 | 0.875 |
| cosine_accuracy@5 | 0.875 |
| cosine_accuracy@10 | 1.0 |
| cosine_precision@1 | 0.625 |
| cosine_precision@3 | 0.2917 |
| cosine_precision@5 | 0.175 |
| cosine_precision@10 | 0.1 |
| cosine_recall@1 | 0.625 |
| cosine_recall@3 | 0.875 |
| cosine_recall@5 | 0.875 |
| cosine_recall@10 | 1.0 |
| cosine_ndcg@10 | 0.8058 |
| cosine_mrr@10 | 0.7448 |
| **cosine_map@100** | **0.7448** |
#### Information Retrieval
* Dataset: `dim_128`
* Evaluated with [InformationRetrievalEvaluator
](https://sbert.net/docs/package_reference/sentence_transformer/evaluation.html#sentence_transformers.evaluation.InformationRetrievalEvaluator)
| Metric | Value |
|:--------------------|:-----------|
| cosine_accuracy@1 | 0.75 |
| cosine_accuracy@3 | 0.875 |
| cosine_accuracy@5 | 1.0 |
| cosine_accuracy@10 | 1.0 |
| cosine_precision@1 | 0.75 |
| cosine_precision@3 | 0.2917 |
| cosine_precision@5 | 0.2 |
| cosine_precision@10 | 0.1 |
| cosine_recall@1 | 0.75 |
| cosine_recall@3 | 0.875 |
| cosine_recall@5 | 1.0 |
| cosine_recall@10 | 1.0 |
| cosine_ndcg@10 | 0.8609 |
| cosine_mrr@10 | 0.8167 |
| **cosine_map@100** | **0.8167** |
#### Information Retrieval
* Dataset: `dim_64`
* Evaluated with [InformationRetrievalEvaluator
](https://sbert.net/docs/package_reference/sentence_transformer/evaluation.html#sentence_transformers.evaluation.InformationRetrievalEvaluator)
| Metric | Value |
|:--------------------|:-----------|
| cosine_accuracy@1 | 0.75 |
| cosine_accuracy@3 | 0.875 |
| cosine_accuracy@5 | 1.0 |
| cosine_accuracy@10 | 1.0 |
| cosine_precision@1 | 0.75 |
| cosine_precision@3 | 0.2917 |
| cosine_precision@5 | 0.2 |
| cosine_precision@10 | 0.1 |
| cosine_recall@1 | 0.75 |
| cosine_recall@3 | 0.875 |
| cosine_recall@5 | 1.0 |
| cosine_recall@10 | 1.0 |
| cosine_ndcg@10 | 0.8609 |
| cosine_mrr@10 | 0.8167 |
| **cosine_map@100** | **0.8167** |
## Training Details
### Training Dataset
#### Unnamed Dataset
* Size: 76 training samples
* Columns: positive
and anchor
* Approximate statistics based on the first 1000 samples:
| | positive | anchor |
|:--------|:------------------------------------------------------------------------------------|:---------------------------------------------------------------------------------|
| type | string | string |
| details |
1 (AGACTCCATATGGAGTCTAGC CAAACAGGAACA); a reverse template comprising a nucleotide sequence having at least 80, 85 or 95% identity 55 (CGACTCCATATGGAGTC to GAAAGCAATCTGAGGA); and a probe oligonucleotide comprising a nucleotide sequence at least 80, 85 or 95%
| to SEQ ID NO
|
| One potential inhibitor of the NEAR technology is human gDNA. When a throat swab sample is collected from a patient symptomatic for GAS infection, it is possible that human gDNA is also collected on the swab (from immune cells such as white blood cells or from local epithelial cells). In order to assess the impact that human gDNA has on the GAS assay, a study was performed using three different levels of GAS gDNA (25, 250 and 1000 copies) in the presence of 0, 10, 50, 100, 250, 500 or 1000 ng of human gDNA. As shown in FIG. 6, the presence of human gDNA does have an impact on GAS assay performance, and the impact is GAS target concentration dependent. When there is a low copy number of target GAS present in the reaction, 10 ng of human gDNA or more significantly inhibits the assay. At 250 copies of GAS target, the impact of 10 ng of 60 human gDNA is less, and at 1,000 copies of GAS target, the effect of 10 ng of human gDNA on the assay is significantly less. In fact, when 1,000 copies of target is present in the assay, up to 100 ng of human gDNA can be tolerated, albeit with a slower amplification speed and reduced fluorescence signal. Testing of the 501 (IC only) mix showed a more robust response to human gDNA. When the 501 mix was tested in the presence of O copies of target GAS and up to US 10,329,601 B2 23 1,000 ng of human gDNA, the assay still produced a clearly positive signal at 500 ng of human gDNA (even at 1,000 ng of human gDNA the fluorescence signal was still above background). Other Embodiments It is to be understood that while the invention has been described in conjunction with the detailed description 24 thereof, the foregoing description is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims. Other aspects, advantages, and modifications are within the scope of the following claims.
| Impact of Human Genomic DNA (gDNA) on GAS Assay
|
| 25C-4x lyophilization mix, single tube assay format; 50C-2x lyophilization mix, single tube assay format; 25T-4x lyophilization mix, target assay only; 50T-2x lyophilization mix, target assay only; 25I- 4x lyophilization mix, IC assay only; 50I-2x lyophilization mix, internal control (IC) assay only. The GAS NEAR assay can be run on an appropriate platform. For example, the GAS NEAR assay can be run on an Al ere i platform (www.alere.com/ww/en/product-details/ alere-i-strep-a.html). AnA!ere i system consists of an instru ment which provides heating, mixing and fluorescence detection with automated result output, and a set of dispos ables, consisting of the sample receiver (where the elution buffer is stored), a test base ( containing two tubes of lyophilized NEAR reagents) and a transfer device ( designed to transfer 100 µI aliquots of eluted sample from the sample receiver to each of the two tubes containing lyophilized NEAR reagents located in the test base). Suitable dispos ables for use with the Alere i GAS NEAR test include those 60 described in, for example U.S. application Ser. No. 13/242, 999, incorporated herein by reference in its entirety. In addition to containing the reagents necessary for driv ing the GAS NEAR assay, the lyophilized material also contains the lytic agent for GAS, the protein plyC; therefore, 65 GAS lysis does not occur until the lyophilized material is re-suspended. In some cases, the lyophilized material does not contain a lytic agent for GAS, for example, in some US 10,329,601 B2 19 examples, the lyophilized material does not contain the protein plyC. The elution buffer was designed to allow for the rapid release of GAS organisms from clinical sample throat swabs as well as to provide the necessary salts for driving the NEAR assay (both MgSO4 and (NH4)2SO4), in 5 a slightly basic environment. In some examples, the elution buffer also includes an anti-microbial agent or preservative (e.g., ProClin® 950). For the present examples, GAS assay was performed as a two tube assay-a GAS target specific assay in one tube, and an internal control (IC) assay in a second tube (tested side by side on the Alere i).
| annotated as follows
|
* Loss: [MatryoshkaLoss
](https://sbert.net/docs/package_reference/sentence_transformer/losses.html#matryoshkaloss) with these parameters:
```json
{
"loss": "MultipleNegativesRankingLoss",
"matryoshka_dims": [
768,
512,
256,
128,
64
],
"matryoshka_weights": [
1,
1,
1,
1,
1
],
"n_dims_per_step": -1
}
```
### Training Hyperparameters
#### Non-Default Hyperparameters
- `eval_strategy`: epoch
- `per_device_train_batch_size`: 16
- `per_device_eval_batch_size`: 16
- `gradient_accumulation_steps`: 16
- `learning_rate`: 3e-05
- `num_train_epochs`: 40
- `lr_scheduler_type`: cosine
- `warmup_ratio`: 0.2
- `fp16`: True
- `load_best_model_at_end`: True
- `optim`: adamw_torch_fused
#### All Hyperparameters